Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devlin

Showing results (691-700 of 803) with videos related to

Pageof 81
Sort By:
Bone Marrow Transplantation|September 1, 2019
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignanciesRichard J Lin, Theresa A Elko, Sean M Devlin, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2018
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel diseasePaulo G Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Transplantation and Cellular Therapy|October 1, 2022
Pilot Trial of Homebound Hematopoietic Cell TransplantationHeather J Landau, Evelyn Orlando, Elizabeth S Rodriguez, et al.
Blood Advances|June 21, 2021
Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphomaParastoo B Dahi, Jasme Lee, Sean M Devlin, et al.
Physical Review Letters|December 12, 2001
Superdeformation in the doubly magic nucleus (40)(20)Ca(20)E Ideguchi, D G Sarantites, W Reviol, et al.
Brain : a Journal of Neurology|September 8, 2010
The p.M292T NDUFS2 mutation causes complex I-deficient Leigh syndrome in multiple familiesHelen A L Tuppen, Vanessa E Hogan, Langping He, et al.
Brachytherapy|April 7, 2021
ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignanciesKelvin Hong, Olaguoke Akinwande, Lisa Bodei, et al.
Nature Medicine|July 3, 2023
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim resultsJae H Park, Karthik Nath, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulinAmanda L Olson, Parastoo B Dahi, Junting Zheng, et al.
Blood Advances|July 3, 2020
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortalityKitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, et al.
Pageof 81

Showing results (691-700 of 803) with videos related to

Sort By:
Pageof 81
Bone Marrow Transplantation|September 1, 2019
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignanciesRichard J Lin, Theresa A Elko, Sean M Devlin, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2018
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel diseasePaulo G Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Transplantation and Cellular Therapy|October 1, 2022
Pilot Trial of Homebound Hematopoietic Cell TransplantationHeather J Landau, Evelyn Orlando, Elizabeth S Rodriguez, et al.
Blood Advances|June 21, 2021
Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphomaParastoo B Dahi, Jasme Lee, Sean M Devlin, et al.
Physical Review Letters|December 12, 2001
Superdeformation in the doubly magic nucleus (40)(20)Ca(20)E Ideguchi, D G Sarantites, W Reviol, et al.
Brain : a Journal of Neurology|September 8, 2010
The p.M292T NDUFS2 mutation causes complex I-deficient Leigh syndrome in multiple familiesHelen A L Tuppen, Vanessa E Hogan, Langping He, et al.
Brachytherapy|April 7, 2021
ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignanciesKelvin Hong, Olaguoke Akinwande, Lisa Bodei, et al.
Nature Medicine|July 3, 2023
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim resultsJae H Park, Karthik Nath, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulinAmanda L Olson, Parastoo B Dahi, Junting Zheng, et al.
Blood Advances|July 3, 2020
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortalityKitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, et al.
Pageof 81